A BIOAVAILABILITY/BIOEQUIVALENCE AND PHARMACOKINETIC STUDY OF TWO ORAL DOSES OF TORASEMIDE (5 AND 10 mg): PROLONGED-RELEASE VERSUS THE CONVENTIONAL FORMULATION

SUMMARY 1 The main objective of the present study was to compare the bioavailability/bioequivalence of a new prolonged‐release (PR) formulation of torasemide with an immediate‐release (IR) formulation. In addition, we assessed the pharmacokinetics of both formulations, as well as the urine pharmacod...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and experimental pharmacology & physiology 2009-05, Vol.36 (5-6), p.469-477
Hauptverfasser: Barbanoj, MJ, Ballester, MR, Antonijoan, RM, Puntes, M, Gropper, S, Santos, B, Albet, C, Guglietta, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!